Company news
10x Genomics, Inc. (NASDAQ:TXG) news
10x Genomics, Inc. news releases on 6ix. Latest, Jul 13, 2023: 10x Genomics to Report Second Quarter 2023 Financial Results on August 3, 2023
Press releases — page 3
10x Genomics to Report Second Quarter 2023 Financial Results on August 3, 2023
July 12, 2023
CAR T-Cell Study Enabled by 10x Genomics Single Cell Technology Published in Nature Medicine
July 4, 2023
10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx Products
May 31, 2023
10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay
May 23, 2023
10x Genomics Wins Permanent Injunction Against NanoString's CosMx Products
May 16, 2023
10x Genomics Reports First Quarter 2023 Financial Results
May 2, 2023
10x Genomics to Present at the BofA Securities 2023 Healthcare Conference
April 24, 2023
10x Genomics to Report First Quarter 2023 Financial Results on May 3, 2023
April 11, 2023
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference
February 21, 2023
10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023
February 14, 2023
10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meeting
February 5, 2023
10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
January 18, 2023
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 27, 2022
10x Genomics Commercially Launches Xenium Platform for In Situ Analysis
December 7, 2022
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery
November 8, 2022
10x Genomics Reports Third Quarter 2022 Financial Results
November 1, 2022
10x Genomics to Host Investor Day on December 8, 2022
October 30, 2022
10x Genomics to Report Third Quarter Financial Results on November 2, 2022
October 11, 2022
10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
September 1, 2022
10x Genomics Reports Second Quarter 2022 Financial Results
August 7, 2022
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
July 27, 2022
10x Genomics Names Jim Wilbur as Chief Commercial Officer
July 13, 2022
10x Genomics Announces Preliminary Second Quarter 2022 Revenue
July 13, 2022
10x Genomics Advances Leadership and Innovation in Single Cell and Spatial Technologies at 2022 AGBT General Meeting
June 6, 2022
10x Genomics Reports First Quarter 2022 Financial Results
May 3, 2022
10x Genomics to Present at the BofA Securities 2022 Healthcare Conference
April 25, 2022
10x Genomics Launches Two New Products to Unlock Wider Range of Samples for Single Cell Analysis on Chromium
April 13, 2022
10x Genomics to Report First Quarter Financial Results on May 4, 2022
April 6, 2022
10x Genomics to Present at the Cowen 42nd Annual Health Care Conference
February 28, 2022
10x Genomics Showcases Robust Innovation Pipeline at Xperience 2022 Event
February 21, 2022
10x Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Outlook for 2022
February 15, 2022
10x Genomics to Report Fourth Quarter and Full Year 2021 Financial Results on February 16, 2022
January 25, 2022
10x Genomics Adds Global Clinical Research Organizations to Expanded Certified Service Provider Network
January 20, 2022
10x Genomics to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021
10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutive Year
November 30, 2021
10x Genomics Reports Third Quarter 2021 Financial Results
November 2, 2021
10x Genomics Celebrates Opening of Singapore Manufacturing and Commercial Hub
October 24, 2021
10x Genomics to Report Third Quarter Financial Results on November 3, 2021
October 6, 2021
10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
August 30, 2021
10x Genomics Reports Second Quarter 2021 Financial Results
August 3, 2021
Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations
July 26, 2021
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
July 26, 2021
10x Genomics Introduces New Chromium X Series for Single Cell Analysis
July 13, 2021
10x Genomics to Report Second Quarter Financial Results on August 4, 2021
July 6, 2021
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
June 9, 2021
10x Genomics to Participate in Upcoming June Investor Conferences
May 23, 2021
10x Genomics Reports First Quarter 2021 Financial Results
May 4, 2021
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
April 28, 2021
10x Genomics to Report First Quarter Financial Results on May 5, 2021
April 7, 2021
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
March 31, 2021